PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24276076-1	2014	As the first in class steroid 17alpha-hydroxylase/C17,20-lyase (CYP17) inhibitor, abiraterone acetate (of which the active metabolite is abiraterone) has been shown to improve overall survival in patients with castration-resistant prostate cancer (CRPC)--in those who are chemotherapy-naive and those previously treated with docetaxel.	Abiraterone Acetate	82-101	cytokine like 1	Homo sapiens	50-53	
23023354-3	2012	Abiraterone acetate is an orally active, potent and selective inhibitor of 17 a hydroxylase and c 17, 20 lyase, which acts by decreasing the de novo production of androgens with no rise in steroids downstream.	Abiraterone Acetate	0-19	cytokine like 1	Homo sapiens	96-110